AG-0029

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameAG-0029

Drug Alias NameAG-1 (angita pharmaceuticals)dual D2 agonist/H3 antagonist (Angita)dual D2 agonist/H3 antagonist (Angita)dual dopamine 2 agonist/histamine H3 antagonist (Angita)dual dopamine D2 agonist/histamine H3 antagonist (Angita) +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistamine H3 receptor antagonistsDopamine D2 receptor agonists

TargetsHistamine H3 receptorDopamine D2 receptor

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAngita Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAngita Pharmaceuticals

Active IndicationsN/A

Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A